Charles Russell Speechlys advises Apposite Capital on their investment into Mirada Medical
Charles Russell Speechlys has advised healthcare investor Apposite Capital on its £6m investment into medical imaging software business Mirada Medical Limited. Mirada is a leading developer of artificial intelligence (AI) based software which increases the speed and accuracy of cancer treatment planning applications, while delivering a more personalised level of care to patients. Apposite has invested alongside Mirada’s founding investor, Albion Capital, and other private investors.
Sam Gray, Partner at Apposite Capital, commented “We were delighted to work with Richard and team at Charles Russell Speechlys on this deal and appreciated their joined up approach and pragmatic and commercial outlook."
Richard Coleman, Private Equity Partner commented “Medical imaging continues to be enhanced by the possibilities of artificial intelligence and Mirada is at the forefront of those developments. We were delighted to be able to leverage our extensive medtech experience to assist Apposite on this investment."
The Charles Russell Speechlys team, led by Richard Coleman, comprised Rajiv Kakkad and Lydia Zakrzewski (Private Equity), Kirsti Laird (Employment), Caroline Young and Jaclyn Wilkins (Commercial and IP) and Helen Coward and Elliot Michaelson (Tax).
News & Insights
Premier League piracy predicament keeps us ‘hooked’
Commentary on the latest developments at the Premier League regarding piracy of live match content.
Thumbs up – A company that embeds the Like button on its website can be considered a data controller jointly with Facebook
Companies that embed the Facebook “Like” button within their website pages can be considered as a joint data controller.
Charles Russell Speechlys advises Growthpoint Investec African Properties
This is part of GIAP’s strategy to aggregate a quality portfolio of commercial real estate assets across Africa.